Page last updated: 2024-09-03

interleukin-1beta (163-171) and Liver Diseases, Alcoholic

interleukin-1beta (163-171) has been researched along with Liver Diseases, Alcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Allende, DS; Chen, X; Czarnecki, D; Dasarathy, D; Hong, L; Li, X; Liao, Y; McMullen, MR; Nagy, LE; Poulsen, KL; Taylor, V; Wang, H; Yang, J; Yu, M; Zhang, Q; Zhao, J; Zhou, H	1

Other Studies

1 other study(ies) available for interleukin-1beta (163-171) and Liver Diseases, Alcoholic

Article	Year
Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice. Journal of hepatology, 2020, Volume: 73, Issue:6 Topics: Acute-Phase Proteins; Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Humans; Immune Checkpoint Inhibitors; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Liver Diseases, Alcoholic; Mice; Mice, Inbred C57BL; Peptide Fragments; Phosphorylation; Receptors, Interleukin-1; Signal Transduction; Toll-Like Receptors; Treatment Outcome	2020

Article

Year

Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice.

Journal of hepatology, 2020, Volume: 73, Issue:6

Topics: Acute-Phase Proteins; Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Humans; Immune Checkpoint Inhibitors; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Liver Diseases, Alcoholic; Mice; Mice, Inbred C57BL; Peptide Fragments; Phosphorylation; Receptors, Interleukin-1; Signal Transduction; Toll-Like Receptors; Treatment Outcome

2020